These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pancreatic cancer stem cells: association with cell surface markers, prognosis, resistance, metastasis and treatment. Fitzgerald TL; McCubrey JA Adv Biol Regul; 2014 Sep; 56():45-50. PubMed ID: 24925031 [TBL] [Abstract][Full Text] [Related]
3. Pancreatic cancer stem cells: new insight into a stubborn disease. Zhan HX; Xu JW; Wu D; Zhang TP; Hu SY Cancer Lett; 2015 Feb; 357(2):429-37. PubMed ID: 25499079 [TBL] [Abstract][Full Text] [Related]
4. Markers of pancreatic cancer stem cells and their clinical and therapeutic implications. Gzil A; Zarębska I; Bursiewicz W; Antosik P; Grzanka D; Szylberg Ł Mol Biol Rep; 2019 Dec; 46(6):6629-6645. PubMed ID: 31486978 [TBL] [Abstract][Full Text] [Related]
5. The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer. Zhou P; Li B; Liu F; Zhang M; Wang Q; Liu Y; Yao Y; Li D Mol Cancer; 2017 Feb; 16(1):52. PubMed ID: 28245823 [TBL] [Abstract][Full Text] [Related]
6. Biology and clinical applications of pancreatic cancer stem cells. Abel EV; Simeone DM Gastroenterology; 2013 Jun; 144(6):1241-8. PubMed ID: 23622133 [TBL] [Abstract][Full Text] [Related]
7. Targeting notch to eradicate pancreatic cancer stem cells for cancer therapy. Wang Z; Ahmad A; Li Y; Azmi AS; Miele L; Sarkar FH Anticancer Res; 2011 Apr; 31(4):1105-13. PubMed ID: 21508353 [TBL] [Abstract][Full Text] [Related]
8. Pancreatic cancer stem cells: emerging target for designing novel therapy. Li Y; Kong D; Ahmad A; Bao B; Sarkar FH Cancer Lett; 2013 Sep; 338(1):94-100. PubMed ID: 22445908 [TBL] [Abstract][Full Text] [Related]
9. Metastatic activity and chemotherapy resistance in human pancreatic cancer--influence of cancer stem cells. Ischenko I; Seeliger H; Jauch KW; Bruns CJ Surgery; 2009 Sep; 146(3):430-4. PubMed ID: 19715799 [No Abstract] [Full Text] [Related]
10. CUB-domain containing protein 1 represses the epithelial phenotype of pancreatic cancer cells. Miura S; Hamada S; Masamune A; Satoh K; Shimosegawa T Exp Cell Res; 2014 Feb; 321(2):209-18. PubMed ID: 24384474 [TBL] [Abstract][Full Text] [Related]
12. Cancer stem cells: involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics. Tanase CP; Neagu AI; Necula LG; Mambet C; Enciu AM; Calenic B; Cruceru ML; Albulescu R World J Gastroenterol; 2014 Aug; 20(31):10790-801. PubMed ID: 25152582 [TBL] [Abstract][Full Text] [Related]
13. Targeting hypoxic tumor microenvironment in pancreatic cancer. Tao J; Yang G; Zhou W; Qiu J; Chen G; Luo W; Zhao F; You L; Zheng L; Zhang T; Zhao Y J Hematol Oncol; 2021 Jan; 14(1):14. PubMed ID: 33436044 [TBL] [Abstract][Full Text] [Related]
14. Pancreatic cancer stem cells: implications for the treatment of pancreatic cancer. Simeone DM Clin Cancer Res; 2008 Sep; 14(18):5646-8. PubMed ID: 18794070 [TBL] [Abstract][Full Text] [Related]
15. Pancreatic Cancer and Therapy: Role and Regulation of Cancer Stem Cells. Barman S; Fatima I; Singh AB; Dhawan P Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946266 [TBL] [Abstract][Full Text] [Related]
16. Targeting stroma in pancreatic cancer: Promises and failures of targeted therapies. Bahrami A; Khazaei M; Bagherieh F; Ghayour-Mobarhan M; Maftouh M; Hassanian SM; Avan A J Cell Physiol; 2017 Nov; 232(11):2931-2937. PubMed ID: 28083912 [TBL] [Abstract][Full Text] [Related]
17. Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studies. Matsuoka T; Yashiro M World J Gastroenterol; 2016 Jan; 22(2):776-89. PubMed ID: 26811624 [TBL] [Abstract][Full Text] [Related]
18. Cancer stem cell targeting: are we there yet? Jung Y; Kim WY Arch Pharm Res; 2015 Mar; 38(3):414-22. PubMed ID: 25666873 [TBL] [Abstract][Full Text] [Related]
19. Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact. Foroni C; Broggini M; Generali D; Damia G Cancer Treat Rev; 2012 Oct; 38(6):689-97. PubMed ID: 22118888 [TBL] [Abstract][Full Text] [Related]
20. RAD51 as a potential biomarker and therapeutic target for pancreatic cancer. Nagathihalli NS; Nagaraju G Biochim Biophys Acta; 2011 Dec; 1816(2):209-18. PubMed ID: 21807066 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]